D-0455-2025 Class II
FDA drug recall D-0455-2025 was initiated by Torrent Pharma Inc. on May 27, 2025 and is designated Class II. Reason for recall: CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit. Affected quantity: 3672 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 11, 2025
- Initiation Date
- May 27, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3672 Bottles
Product description
Fluoxetine Tablets, USP, 20 mg, 30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-30
Reason for recall
CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.
Distribution pattern
U.S. Nationwide.
Code information
Lot# BDX6K001; Exp. Date 06/30/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0455-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026